Atara Biotherapeutics, Inc.
ATRA
$9.91
-$0.32-3.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -55.77% | -39.60% | -80.04% | -79.59% | -36.75% |
| Total Receivables | -- | -- | -15.45% | 43.30% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 36.34% | -14.62% | -75.86% | -69.98% | -58.82% |
| Total Current Assets | -45.38% | -55.22% | -81.18% | -79.93% | -60.31% |
|
|
|||||
| Total Current Assets | -45.38% | -55.22% | -81.18% | -79.93% | -60.31% |
| Net Property, Plant & Equipment | -39.94% | -78.34% | -82.64% | -77.15% | -78.15% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -17.48% | -68.71% | -71.45% | -73.76% | -74.31% |
| Total Assets | -43.03% | -67.77% | -81.45% | -78.86% | -68.54% |
|
|
|||||
| Total Accounts Payable | -53.23% | -53.97% | -97.09% | -85.18% | -66.46% |
| Total Accrued Expenses | -65.16% | -84.38% | -84.14% | -77.64% | -58.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -51.07% | -92.71% | -92.61% | -86.68% | -83.98% |
| Total Finance Division Other Current Liabilities | 12.45% | -91.25% | -89.04% | -90.82% | -98.51% |
| Total Other Current Liabilities | 12.45% | -91.25% | -89.04% | -90.82% | -98.51% |
| Total Current Liabilities | -52.98% | -88.21% | -88.91% | -88.42% | -90.18% |
|
|
|||||
| Total Current Liabilities | -52.98% | -88.21% | -88.91% | -88.42% | -90.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -43.07% | -67.62% | -68.75% | -57.42% | -60.14% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.04% | 3.39% | -17.72% | -19.71% | 1.87% |
| Total Liabilities | -19.35% | -51.06% | -71.54% | -71.36% | -68.47% |
|
|
|||||
| Common Stock & APIC | 0.74% | 1.39% | 1.33% | 1.56% | 3.67% |
| Retained Earnings | -0.83% | -0.47% | 1.59% | 1.15% | 0.29% |
| Treasury Stock & Other | -- | -- | -87.50% | -90.91% | -- |
| Total Common Equity | -5.58% | 32.25% | 60.42% | 59.54% | 68.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.58% | 32.25% | 60.42% | 59.54% | 68.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.58% | 32.25% | 60.42% | 59.54% | 68.39% |
|
|
|||||